Loading...
XLON
AGR
Market cap2.09bUSD
Apr 24, Last price  
48.14GBP
1D
0.17%
1Q
32.84%
Jan 2017
-15.19%
IPO
-8.09%
Name

Assura PLC

Chart & Performance

D1W1MN
P/E
—
P/S
991.66
EPS
—
Div Yield, %
5.19%
Shrs. gr., 5y
4.43%
Rev. gr., 5y
9.03%
Revenues
158m
+3.82%
3,758,2247,016,00016,123,000047,571,00055,761,00062,119,00034,100,00037,100,00039,900,00051,100,00061,000,00071,100,00086,100,000102,400,000111,500,000121,000,000137,300,000152,000,000157,800,000
Net income
-29m
L-75.84%
2,231,000-12,499,00018,900,0000-108,763,000-8,682,00015,072,000-60,700,00014,100,00035,000,00037,200,00027,900,00095,300,00071,800,00084,000,00078,900,000108,300,000155,900,000-119,200,000-28,800,000
CFO
102m
+8.82%
2,190,000760,000149,0005,295,000-11,746,0002,859,00013,400,00012,900,0007,900,00016,900,00022,900,00039,000,00049,900,00072,900,00066,300,00077,400,00094,600,00094,100,000102,400,000
Dividend
Sep 05, 20240.84 GBP/sh
Earnings
May 19, 2025

Profile

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.
URL
https://www.assuraplc.com/
IPO date
Jan 28, 2015
Employees
86
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
157,800
3.82%
152,000
10.71%
Cost of revenue
28,500
26,600
Unusual Expense (Income)
NOPBT
129,300
125,400
NOPBT Margin
81.94%
82.50%
Operating Taxes
100
700
Tax Rate
0.08%
0.56%
NOPAT
129,200
124,700
Net income
(28,800)
-75.84%
(119,200)
-176.46%
Dividends
(85,500)
(88,900)
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
300
400
Long-term debt
1,258,400
1,252,200
Deferred revenue
4,200
35,700
Other long-term liabilities
46,800
Net debt
1,205,800
1,116,300
Cash flow
Cash from operating activities
102,400
94,100
CAPEX
(2,800)
(15,200)
Cash from investing activities
(97,700)
(130,400)
Cash from financing activities
(87,300)
(89,200)
FCF
60,600
128,600
Balance
Cash
33,200
118,000
Long term investments
19,700
18,300
Excess cash
45,010
128,700
Stockholders' equity
309,400
894,600
Invested Capital
2,685,090
2,794,800
ROIC
4.72%
4.39%
ROCE
4.74%
4.41%
EV
Common stock shares outstanding
2,970,682
2,958,385
Price
Market cap
EV
EBITDA
129,600
125,600
EV/EBITDA
Interest
27,100
31,200
Interest/NOPBT
20.96%
24.88%